![](https://monteverdelaw.com/wp-content/uploads/case-logo/osiris-therapeutics-inc.png)
We are investigating Osiris Therapeutics, Inc. (NasdaqGM: OSIR) relating to the sale of the Company to Smith & Nephew plc. Under the transaction, Osiris shareholders will receive $19.00 in cash for each share of Osiris stock they hold.
We are investigating Osiris Therapeutics, Inc. (NasdaqGM: OSIR) relating to the sale of the Company to Smith & Nephew plc. Under the transaction, Osiris shareholders will receive $19.00 in cash for each share of Osiris stock they hold.